<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02902614</url>
  </required_header>
  <id_info>
    <org_study_id>Embryo Biopsy</org_study_id>
    <nct_id>NCT02902614</nct_id>
  </id_info>
  <brief_title>Side of Embryo Biopsy Interfering Implantation Potential</brief_title>
  <official_title>Effect of Embryo Biopsy Side on Post Biopsy Blastocyst Structurs and Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahmad Mustafa Mohamed Metwalley</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ibn Sina Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Al Baraka Fertility Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Selection of side of embryo biopsy that will not interfering with implantation power of
      developed blastocyst embryo during biopsy procedure arranged for PGT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During process of embryo biopsy, it was indicated to avoid contacting cells closer to inner
      cell mass as it can decrease the quality of embryo and its structural composition. However,
      recommendation for collection from the trophectoderm (TE) side is indicated.

      Absence of differentiation during cleavage-stage or morula stage at day 3 and day 4
      respectively, will present the needful to focus a specific location for embryo biopsy during
      pre-blastocyst stages for embryo going to do genetic testing before implantation or embryo
      transfer.

      In articulation around the second polar body or the animal pole of embryo, collection of the
      cell from the vegetal pole in crospondence to avoide collection form the animal pole is to be
      compare the results of implantation for biopsy done using the animal pole side or the random
      non organized biosy procedure.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blastocyst location of ICM at day 5</measure>
    <time_frame>2 months</time_frame>
    <description>describing the location of the inner cell mass (ICM) in location to the zona peluceda (ZP) drilling opening.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation power</measure>
    <time_frame>2 months</time_frame>
    <description>calculating the pregnancy rate for cases after biopsy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Preimplantation Diagnosis</condition>
  <arm_group>
    <arm_group_label>Vegetal Pole blastomer embryo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>for day 3 embryo biopsy / cleavage stage: Blastomere collection from opposite side to the 2nd polar body or from vegetal pole.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Animal Pole blastomer embryo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>for day 3 embryo biopsy / cleavage stage: Blastomere collection from and side around the 2nd polar body and not the vegetal pole.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vegetal Pole blastomer embryo</intervention_name>
    <description>for day 3 embryo biopsy / cleavage stage</description>
    <arm_group_label>Vegetal Pole blastomer embryo</arm_group_label>
    <arm_group_label>Animal Pole blastomer embryo</arm_group_label>
    <other_name>Biopsy embryo from sides considered far from ICM location.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Animal Pole blastomer embryo</intervention_name>
    <description>for day 3 embryo biopsy / cleavage stage</description>
    <arm_group_label>Vegetal Pole blastomer embryo</arm_group_label>
    <arm_group_label>Animal Pole blastomer embryo</arm_group_label>
    <other_name>Random biopsy without considering specific location</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  grade 1 or 2 embryos at eight cell stage or 8-1/ 8-2 embryo quality.

        Exclusion Criteria:

          -  grade 3 embryo at day 3, or 8-3 embryos.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmad M Metwalley</last_name>
    <role>Principal Investigator</role>
    <affiliation>Al Baraka Fertility Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ahmad Mustafa Metwalley</name>
      <address>
        <city>Bahrain</city>
        <state>Manama</state>
        <zip>15006</zip>
        <country>Bahrain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ibn Sina IVF Center- Ibn Sina Hospital</name>
      <address>
        <city>Sohag</city>
        <zip>15006</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bahrain</country>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://www.jbc.org/content/282/17/12822.full</url>
    <description>Oct4 and Sox2 Directly Regulate Expression of Another Pluripotency Transcription Factor, Zfp206, in Embryonic Stem Cells</description>
  </link>
  <link>
    <url>http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081962</url>
    <description>Oct4/Sox2 Binding Sites Contribute to Maintaining Hypomethylation of the Maternal Igf2/H19 Imprinting Control Region</description>
  </link>
  <link>
    <url>http://molehr.oxfordjournals.org/content/16/11/856/T1.expansion</url>
    <description>Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation</description>
  </link>
  <link>
    <url>http://dx.doi.org/10.1016/S0092-8674(00)81769-9</url>
    <description>Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/12514105</url>
    <description>Multipotent cell lineages in early mouse development depend on SOX2 function</description>
  </link>
  <link>
    <url>http://humrep.oxfordjournals.org/content/25/1/6.full</url>
    <description>Children born after preimplantation genetic diagnosis show no increase in congenital anomalies</description>
  </link>
  <results_reference>
    <citation>Tscherne RJ, Capitano G. High-pressure liquid chromatographic separation of pharmaceutical compounds using a mobile phase containing silver nitrate. J Chromatogr. 1977 Jun 11;136(2):337-41.</citation>
    <PMID>195970</PMID>
  </results_reference>
  <results_reference>
    <citation>Geraedts J, Sermon K. Preimplantation genetic screening 2.0: the theory. Mol Hum Reprod. 2016 Aug;22(8):839-44. doi: 10.1093/molehr/gaw033. Epub 2016 Jun 2. Review.</citation>
    <PMID>27256482</PMID>
  </results_reference>
  <results_reference>
    <citation>Balakier H, Sojecki A, Motamedi G, Librach C. Impact of multinucleated blastomeres on embryo developmental competence, morphokinetics, and aneuploidy. Fertil Steril. 2016 Sep 1;106(3):608-614.e2. doi: 10.1016/j.fertnstert.2016.04.041. Epub 2016 May 18.</citation>
    <PMID>27206619</PMID>
  </results_reference>
  <results_reference>
    <citation>Cimadomo D, Capalbo A, Ubaldi FM, Scarica C, Palagiano A, Canipari R, Rienzi L. The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis. Biomed Res Int. 2016;2016:7193075. doi: 10.1155/2016/7193075. Epub 2016 Jan 28. Review.</citation>
    <PMID>26942198</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Z, Ang WT, Tan SY, Latt WT. Automatic segmentation of zona pellucida and its application in cleavage-stage embryo biopsy position selection. Conf Proc IEEE Eng Med Biol Soc. 2015;2015:3859-64. doi: 10.1109/EMBC.2015.7319236.</citation>
    <PMID>26737136</PMID>
  </results_reference>
  <results_reference>
    <citation>Dahdouh EM, Balayla J, Audibert F; Genetics Committee, Wilson RD, Audibert F, Brock JA, Campagnolo C, Carroll J, Chong K, Gagnon A, Johnson JA, MacDonald W, Okun N, Pastuck M, Vall√©e-Pouliot K. Technical Update: Preimplantation Genetic Diagnosis and Screening. J Obstet Gynaecol Can. 2015 May;37(5):451-63. Review.</citation>
    <PMID>26168107</PMID>
  </results_reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2016</study_first_submitted>
  <study_first_submitted_qc>September 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2016</study_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Al Baraka Fertility Hospital</investigator_affiliation>
    <investigator_full_name>Ahmad Mustafa Mohamed Metwalley</investigator_full_name>
    <investigator_title>IVF laboratory manager</investigator_title>
  </responsible_party>
  <keyword>embryo biopsy</keyword>
  <keyword>preimplantation genetic testing</keyword>
  <keyword>animal pole</keyword>
  <keyword>vegetal pole</keyword>
  <keyword>day 3 embryo biopsy</keyword>
  <keyword>embryo implantation</keyword>
  <keyword>Blastomeres</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After abstract submission or after final approval for scientific paper</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

